Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

By Evin Geneviève   Marijke Fleur Sernee   Masters Colin L.  

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 351-372

Adis International

Access to resources Recommend Favorite

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 3-25

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

By D'Onofrio Grazia   Panza Francesco   Frisardi Vincenza   Solfrizzi Vincenzo   Imbimbo Bruno P   Paroni Giulia   Cascavilla Leandro   Seripa Davide   Pilotto Alberto  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 19-37

Informa Healthcare

Access to resources Recommend Favorite

Views on Amyloid Hypothesis and Secretase Inhibitors for Treating Alzheimer's Disease: Progress and Problems

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4295-4312

Bentham Science Publishers

Access to resources Recommend Favorite

γ-Secretase Inhibitors for Alzheimer's Disease: Balancing Efficacy and Toxicity

By Barten Donna M.   Meredith Jere E.   Zaczek Robert   Houston John G.   Albright Charles F.  

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite